207 related articles for article (PubMed ID: 32038177)
1. The Epilepsy of Infancy With Migrating Focal Seizures: Identification of
Mao X; Bruneau N; Gao Q; Becq H; Jia Z; Xi H; Shu L; Wang H; Szepetowski P; Aniksztejn L
Front Cell Neurosci; 2020; 14():1. PubMed ID: 32038177
[TBL] [Abstract][Full Text] [Related]
2. Early Treatment with Quinidine in 2 Patients with Epilepsy of Infancy with Migrating Focal Seizures (EIMFS) Due to Gain-of-Function KCNT1 Mutations: Functional Studies, Clinical Responses, and Critical Issues for Personalized Therapy.
Dilena R; DiFrancesco JC; Soldovieri MV; Giacobbe A; Ambrosino P; Mosca I; Galli MA; Guez S; Fumagalli M; Miceli F; Cattaneo D; Darra F; Gennaro E; Zara F; Striano P; Castellotti B; Gellera C; Varesio C; Veggiotti P; Taglialatela M
Neurotherapeutics; 2018 Oct; 15(4):1112-1126. PubMed ID: 30112700
[TBL] [Abstract][Full Text] [Related]
3. A De Novo Mutation in the Sodium-Activated Potassium Channel KCNT2 Alters Ion Selectivity and Causes Epileptic Encephalopathy.
Gururaj S; Palmer EE; Sheehan GD; Kandula T; Macintosh R; Ying K; Morris P; Tao J; Dias KR; Zhu Y; Dinger ME; Cowley MJ; Kirk EP; Roscioli T; Sachdev R; Duffey ME; Bye A; Bhattacharjee A
Cell Rep; 2017 Oct; 21(4):926-933. PubMed ID: 29069600
[TBL] [Abstract][Full Text] [Related]
4. KCNT1-related epilepsies and epileptic encephalopathies: phenotypic and mutational spectrum.
Bonardi CM; Heyne HO; Fiannacca M; Fitzgerald MP; Gardella E; Gunning B; Olofsson K; Lesca G; Verbeek N; Stamberger H; Striano P; Zara F; Mancardi MM; Nava C; Syrbe S; Buono S; Baulac S; Coppola A; Weckhuysen S; Schoonjans AS; Ceulemans B; Sarret C; Baumgartner T; Muhle H; Portes VD; Toulouse J; Nougues MC; Rossi M; Demarquay G; Ville D; Hirsch E; Maurey H; Willems M; de Bellescize J; Altuzarra CD; Villeneuve N; Bartolomei F; Picard F; Hornemann F; Koolen DA; Kroes HY; Reale C; Fenger CD; Tan WH; Dibbens L; Bearden DR; Møller RS; Rubboli G
Brain; 2021 Dec; 144(12):3635-3650. PubMed ID: 34114611
[TBL] [Abstract][Full Text] [Related]
5. Case Report: Causative
Gong P; Jiao X; Yu D; Yang Z
Front Genet; 2021; 12():649556. PubMed ID: 34276763
[No Abstract] [Full Text] [Related]
6. An Epilepsy-Associated KCNT1 Mutation Enhances Excitability of Human iPSC-Derived Neurons by Increasing Slack K
Quraishi IH; Stern S; Mangan KP; Zhang Y; Ali SR; Mercier MR; Marchetto MC; McLachlan MJ; Jones EM; Gage FH; Kaczmarek LK
J Neurosci; 2019 Sep; 39(37):7438-7449. PubMed ID: 31350261
[TBL] [Abstract][Full Text] [Related]
7. De novo KCNT1 mutations in early-onset epileptic encephalopathy.
Ohba C; Kato M; Takahashi N; Osaka H; Shiihara T; Tohyama J; Nabatame S; Azuma J; Fujii Y; Hara M; Tsurusawa R; Inoue T; Ogata R; Watanabe Y; Togashi N; Kodera H; Nakashima M; Tsurusaki Y; Miyake N; Tanaka F; Saitsu H; Matsumoto N
Epilepsia; 2015 Sep; 56(9):e121-8. PubMed ID: 26140313
[TBL] [Abstract][Full Text] [Related]
8. K
Gertler TS; Cherian S; DeKeyser JM; Kearney JA; George AL
Neurobiol Dis; 2022 Jun; 168():105713. PubMed ID: 35346832
[TBL] [Abstract][Full Text] [Related]
9. Quantitative analysis and EEG markers of KCNT1 epilepsy of infancy with migrating focal seizures.
Kuchenbuch M; Benquet P; Kaminska A; Roubertie A; Carme E; de Saint Martin A; Hirsch E; Dubois F; Laroche C; Barcia G; Chemaly N; Milh M; Villeneuve N; Sauleau P; Modolo J; Wendling F; Nabbout R
Epilepsia; 2019 Jan; 60(1):20-32. PubMed ID: 30525185
[TBL] [Abstract][Full Text] [Related]
10. Characterization of two de novoKCNT1 mutations in children with malignant migrating partial seizures in infancy.
Rizzo F; Ambrosino P; Guacci A; Chetta M; Marchese G; Rocco T; Soldovieri MV; Manocchio L; Mosca I; Casara G; Vecchi M; Taglialatela M; Coppola G; Weisz A
Mol Cell Neurosci; 2016 Apr; 72():54-63. PubMed ID: 26784557
[TBL] [Abstract][Full Text] [Related]
11. The Phe932Ile mutation in KCNT1 channels associated with severe epilepsy, delayed myelination and leukoencephalopathy produces a loss-of-function channel phenotype.
Evely KM; Pryce KD; Bhattacharjee A
Neuroscience; 2017 May; 351():65-70. PubMed ID: 28366665
[TBL] [Abstract][Full Text] [Related]
12. Impaired motor skill learning and altered seizure susceptibility in mice with loss or gain of function of the Kcnt1 gene encoding Slack (K
Quraishi IH; Mercier MR; McClure H; Couture RL; Schwartz ML; Lukowski R; Ruth P; Kaczmarek LK
Sci Rep; 2020 Feb; 10(1):3213. PubMed ID: 32081855
[TBL] [Abstract][Full Text] [Related]
13. Cardiac metabolic effects of K
Smith CO; Wang YT; Nadtochiy SM; Miller JH; Jonas EA; Dirksen RT; Nehrke K; Brookes PS
FASEB J; 2018 Jun; 32(11):fj201800139R. PubMed ID: 29863912
[TBL] [Abstract][Full Text] [Related]
14. In silico model reveals the key role of GABA in KCNT1-epilepsy in infancy with migrating focal seizures.
Kuchenbuch M; Nabbout R; Yochum M; Sauleau P; Modolo J; Wendling F; Benquet P
Epilepsia; 2021 Mar; 62(3):683-697. PubMed ID: 33617692
[TBL] [Abstract][Full Text] [Related]
15. Targeting K
Cole BA; Clapcote SJ; Muench SP; Lippiat JD
Trends Pharmacol Sci; 2021 Aug; 42(8):700-713. PubMed ID: 34074526
[TBL] [Abstract][Full Text] [Related]
16. Small-molecule inhibitors of Slack potassium channels as potential therapeutics for childhood epilepsies.
M Qunies A; A Emmitte K
Pharm Pat Anal; 2022 Mar; 11(2):45-56. PubMed ID: 35369761
[TBL] [Abstract][Full Text] [Related]
17. Discovery of the First Orally Available, Selective K
Griffin AM; Kahlig KM; Hatch RJ; Hughes ZA; Chapman ML; Antonio B; Marron BE; Wittmann M; Martinez-Botella G
ACS Med Chem Lett; 2021 Apr; 12(4):593-602. PubMed ID: 33859800
[TBL] [Abstract][Full Text] [Related]
18. [Early infantile epileptic encephalopathy type 14: three cases of epilepsy in infancy with migrating focal seizures due to KCNT1 mutations].
Kholin AA; Zavadenko NN; Fedonyuk ID; Antonets AV; Mukhin KY; Malov AG; Vshivkov MI; Anisimov GV; Il'ina ES
Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(7. Vyp. 2):74-82. PubMed ID: 31532594
[TBL] [Abstract][Full Text] [Related]
19. Disease-causing Slack potassium channel mutations produce opposite effects on excitability of excitatory and inhibitory neurons.
Wu J; Quraishi IH; Zhang Y; Bromwich M; Kaczmarek LK
Cell Rep; 2024 Mar; 43(3):113904. PubMed ID: 38457342
[TBL] [Abstract][Full Text] [Related]
20. Antisense oligonucleotide therapy for KCNT1 encephalopathy.
Burbano LE; Li M; Jancovski N; Jafar-Nejad P; Richards K; Sedo A; Soriano A; Rollo B; Jia L; Gazina EV; Piltz S; Adikusuma F; Thomas PQ; Kopsidas H; Rigo F; Reid CA; Maljevic S; Petrou S
JCI Insight; 2022 Dec; 7(23):. PubMed ID: 36173683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
